ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,007,000 | -80.3% | 71,500 | -57.9% | 0.56% | -42.0% |
Q4 2017 | $5,119,000 | -43.4% | 170,000 | -29.2% | 0.97% | -40.3% |
Q3 2017 | $9,041,000 | +29.7% | 240,000 | -4.0% | 1.62% | -16.9% |
Q2 2017 | $6,973,000 | -74.1% | 250,000 | -68.1% | 1.95% | -69.4% |
Q1 2017 | $26,911,000 | +211.0% | 782,756 | +160.9% | 6.38% | +98.3% |
Q4 2016 | $8,652,000 | +4.6% | 300,000 | +15.4% | 3.22% | +3.6% |
Q3 2016 | $8,270,000 | +196.2% | 260,000 | +202.3% | 3.11% | +131.4% |
Q2 2016 | $2,792,000 | – | 85,999 | – | 1.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |